Hologic, Inc. vs Pfizer, Inc. — Stock Comparison

HOLX
Hologic, Inc.
$76.01
vs
PFE
Pfizer, Inc.
$26.33
▼ 1.39%
Q·Score Winner
Pfizer, Inc.
PFE6.5/10vs 6.1/10

Q·Score Breakdown

6.1
Neutral
Overall
6.5
Neutral
7
Quality
7.4
9.2
Health
7
4.4
Growth
5.6
6.5
Valuation
6.7
2.5
Sentiment
5.2
HOLX

Clean balance sheet with low leverage (0.5× debt-to-equity).

cautious analyst consensus — few Buy ratings.

PFE

Strong profitability with 12% net profit margins.

analyst sentiment is cautious.

Analyst Consensus

HOLD
Target $76.67 (+0.9%)
9 analysts
HOLD
Target $29.00 (+10.2%)
27 analysts

Fundamentals

HOLX
PFE
31.5×
Trailing P/E
19.4×
15.6×
Forward P/E
9.4×
13.2%
Profit Margin
12.4%
60.4%
Gross Margin
75.8%
10.9%
ROE
8.9%
2.5%
Revenue Growth
-1.2%
-9.2%
Earnings Growth
0.70
Beta
0.39
Price / Book
$17.0B
Market Cap
$149.8B
$52 – $76
52-Week Range
$22 – $29

Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →